Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaxart Inc (NQ: VXRT ) 0.9084 -0.0016 (-0.18%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Vaxart Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside August 15, 2024 Oppenheimer initiates Vaxart coverage with an Outperform rating and $4 price target, citing a bullish outlook on its oral vaccines for COVID-19 and norovirus. Via Benzinga Exposures COVID-19 VXRT Stock Earnings: Vaxart Misses EPS, Beats Revenue for Q2 2024 August 08, 2024 VXRT stock results show that Vaxart missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace $1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying June 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 18, 2024 Via Benzinga Recap: Vaxart Q4 Earnings March 14, 2024 Via Benzinga Vaxart's Earnings: A Preview March 13, 2024 Via Benzinga What's Going On With Vaxart Stock Today? January 17, 2024 Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services. Via Benzinga Vaxart's Earnings Outlook November 01, 2023 Via Benzinga Vaxart Stock Is Moving Higher After The Bell: What's Going On? June 17, 2024 Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project... Via Benzinga Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering June 14, 2024 Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID-19 vaccine study. Via Benzinga Exposures COVID-19 Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket June 14, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 14, 2024 Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session June 13, 2024 Via Benzinga Palo Alto Networks Shares Drop After Q3 Results, In-Line Guidance: The Details May 20, 2024 Palo Alto Networks reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.25 by 5.6%. Quarterly sales clocked in at $1.985 billion which beat the analyst... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 14, 2024 Via Benzinga VXRT Stock Earnings: Vaxart Meets EPS, Beats Revenue for Q1 2024 May 13, 2024 VXRT stock results show that Vaxart met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session May 13, 2024 Via Benzinga Vaxart Stock Climbs After Blockbuster Q1 Revenue May 13, 2024 Vaxart reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in at $2.181 million, beating the analyst consensus estimate of $800,000 by... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 10, 2024 Via Benzinga Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024? April 09, 2024 These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around. Via InvestorPlace VXRT Stock Earnings: Vaxart Beats EPS, Beats Revenue for Q4 2023 March 14, 2024 VXRT stock results show that Vaxart beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Intraday Session January 31, 2024 Via Benzinga Earnings Scheduled For March 14, 2024 March 14, 2024 Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. Via Benzinga Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 31, 2024 Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 16, 2024 Via Benzinga What's Going On With Vaxart (VXRT) Stock? January 16, 2024 Vaxart shares are trading higher by 17.8% Tuesday morning amid multiple news items. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services. Via Benzinga Earnings Scheduled For November 2, 2023 November 02, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. Via Benzinga Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket October 30, 2023 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday October 30, 2023 It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage! Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.